Callery, LLC

Callery, LLC is a chemical manufacturing company that produces high-quality reagents for the life sciences and specialty chemicals sectors, supporting advancements in various manufacturing processes. Founded in 2017 and headquartered in Evans, US, Callery, LLC focuses on delivering specialized chemical solutions. The company was acquired by Ascensus Specialties LLC in September 2019, with the deal expected to close by October 2019. The CEO, Harry Rathore, has a background in leading innovative projects within the chemical industry.

Callery specializes in high-quality reagents primarily for the life sciences and specialty chemicals industries. Their core offerings include alkali metals, boranes, borohydrides, boronic acids, esters, and specialty alcoholates, designed to enhance chemical synthesis and improve manufacturing processes across various applications. The company serves clients in North America, Europe, and Asia, including pharmaceutical companies and research institutions. Callery generates revenue through direct sales of its reagents and specialty chemicals to business clients in the life sciences and specialty chemical sectors.

Transactions are conducted on a B2B basis, with pricing based on the type and quantity of reagents ordered. Key revenue drivers include cGMP-compliant APIs and custom reagents, ensuring compliance with client needs while maintaining strong relationships for timely delivery. The company’s future growth strategy includes expanding its product line with new reagents tailored for emerging applications in the life sciences sector. Callery plans to enter new markets in Asia and Europe by 2022.

Recent funding from the acquisition by Ascensus Specialties LLC will support these expansion initiatives, allowing for enhanced product development and market penetration.